Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler » 20:13
09/23/20
09/23
20:13
09/23/20
20:13
TDOC

Teladoc

$209.22 /

-6.315 (-2.93%)

, AMZN

Amazon.com

$2,997.85 /

-133.26 (-4.26%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland keeps his Overweight rating and $232 price target on Teladoc (TDOC). The analyst states that the expansion of Amazon Care pilot program outside of Seattle to the entire state of Washington by Amazon.com (AMZN) is still a "far cry" from "true telehealth" and does not pose an imminent or a medium-term threat to Teladoc's "sophisticated" Virtual Care platform.

ShowHide Related Items >><<
TDOC Teladoc
$209.22 /

-6.315 (-2.93%)

AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

TDOC Teladoc
$209.22 /

-6.315 (-2.93%)

09/22/20
Top five analyst initiations
09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

09/23/20 Benchmark
Benchmark says Microsoft partnership can be 'big driver' for Kratos
09/22/20 KeyBanc
Echelon Prime Bike not 'significant impediment' to Peloton growth, says KeyBanc
09/22/20
Fly Intel: Top five analyst upgrades
09/22/20 Loop Capital
Global Payments initiated with a Buy at Loop Capital
TDOC Teladoc
$209.22 /

-6.315 (-2.93%)

AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

TDOC Teladoc
$209.22 /

-6.315 (-2.93%)

AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

TDOC Teladoc
$209.22 /

-6.315 (-2.93%)

AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

TDOC Teladoc
$209.22 /

-6.315 (-2.93%)

AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

AMZN Amazon.com
$2,997.85 /

-133.26 (-4.26%)

Tuesday
Initiation
Top five analyst initiations » 10:11
09/22/20
09/22
10:11
09/22/20
10:11
TDOC

Teladoc

$203.50 /

+0.74 (+0.36%)

, PYPL

PayPal

$183.25 /

+0.03 (+0.02%)

, SQ

Square

$149.64 /

-1.39 (-0.92%)

, IMMP

Immutep

$1.80 /

-0.03 (-1.64%)

, BPOP

Popular

$37.18 /

+0.21 (+0.57%)

, FISV

Fiserv

$98.96 /

-0.65 (-0.65%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Teladoc (TDOC) initiated with a Buy at DA Davidson. 2. PayPal (PYPL) and Square (SQ) both initiated with a Buy at Loop Capital. 3. Immutep (IMMP) initiated with a Buy at Alliance Global Partners. 4. Popular (BPOP) initiated with a Neutral at UBS. 5. Fiserv (FISV) initiated with a Hold at Loop Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TDOC Teladoc
$203.50 /

+0.74 (+0.36%)

SQ Square
$149.64 /

-1.39 (-0.92%)

PYPL PayPal
$183.25 /

+0.03 (+0.02%)

IMMP Immutep
$1.80 /

-0.03 (-1.64%)

FISV Fiserv
$98.96 /

-0.65 (-0.65%)

BPOP Popular
$37.18 /

+0.21 (+0.57%)

TDOC Teladoc
$203.50 /

+0.74 (+0.36%)

09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
PYPL PayPal
$183.25 /

+0.03 (+0.02%)

09/22/20 Loop Capital
PayPal initiated with a Buy at Loop Capital
09/15/20 Baird
PayPal's Venmo remains favored digital wallet by 'wide margin,' says Baird
08/31/20 Keefe Bruyette
KBW boosts PayPal target to $238, names best idea for second half
08/28/20 Truist
MasterCard price target raised to $415 from $375 at Truist
SQ Square
$149.64 /

-1.39 (-0.92%)

09/22/20 Loop Capital
Square initiated with a Buy at Loop Capital
09/16/20 Mizuho
Square lending product could add 10% in gross profit, says Mizuho
08/27/20 Mizuho
Mizuho starts Square with Buy rating, $225 price target
08/26/20 Mizuho
Square initiated with a Buy at Mizuho
IMMP Immutep
$1.80 /

-0.03 (-1.64%)

09/22/20 Alliance Global Partners
Immutep initiated with a Buy at Alliance Global Partners
06/02/20 JonesTrading
Immutep ASCO presentations point to expanding utility of efti, says JonesTrading
BPOP Popular
$37.18 /

+0.21 (+0.57%)

09/22/20 UBS
Popular initiated with a Neutral at UBS
07/07/20 RBC Capital
Popular price target lowered to $48 from $58 at RBC Capital
03/27/20 BTIG
Popular price target lowered to $54 from $60 at BTIG
03/12/20 BTIG
Popular price target lowered to $60 from $69 at BTIG
FISV Fiserv
$98.96 /

-0.65 (-0.65%)

09/22/20 Loop Capital
Fiserv initiated with a Hold at Loop Capital
09/16/20 Compass Point
Fiserv initiated with a Buy at Compass Point
09/14/20 Baird
Fiserv desiganted a Fresh Pick at Baird
09/10/20 Mizuho
Fiserv price target raised to $160 from $145 at Mizuho
TDOC Teladoc
$203.50 /

+0.74 (+0.36%)

SQ Square
$149.64 /

-1.39 (-0.92%)

PYPL PayPal
$183.25 /

+0.03 (+0.02%)

FISV Fiserv
$98.96 /

-0.65 (-0.65%)

BPOP Popular
$37.18 /

+0.21 (+0.57%)

TDOC Teladoc
$203.50 /

+0.74 (+0.36%)

SQ Square
$149.64 /

-1.39 (-0.92%)

PYPL PayPal
$183.25 /

+0.03 (+0.02%)

TDOC Teladoc
$203.50 /

+0.74 (+0.36%)

SQ Square
$149.64 /

-1.39 (-0.92%)

PYPL PayPal
$183.25 /

+0.03 (+0.02%)

FISV Fiserv
$98.96 /

-0.65 (-0.65%)

TDOC Teladoc
$203.50 /

+0.74 (+0.36%)

SQ Square
$149.64 /

-1.39 (-0.92%)

PYPL PayPal
$183.25 /

+0.03 (+0.02%)

FISV Fiserv
$98.96 /

-0.65 (-0.65%)

On The Fly
Amazon upgrade, PayPal initiation among today's top calls on Wall Street » 10:09
09/22/20
09/22
10:09
09/22/20
10:09
AMZN

Amazon.com

$3,017.89 /

+56.89 (+1.92%)

, PYPL

PayPal

$182.48 /

-0.74 (-0.40%)

, SQ

Square

$149.84 /

-1.19 (-0.79%)

, TDOC

Teladoc

$202.66 /

-0.1 (-0.05%)

, CVNA

Carvana

$216.77 /

+42.98 (+24.73%)

, PGR

Progressive

$96.20 /

-1.16 (-1.19%)

, ALL

Allstate

$93.18 /

+1.185 (+1.29%)

Check out today's top…

ShowHide Related Items >><<
TDOC Teladoc
$202.66 /

-0.1 (-0.05%)

SQ Square
$149.84 /

-1.19 (-0.79%)

PYPL PayPal
$182.48 /

-0.74 (-0.40%)

PGR Progressive
$96.20 /

-1.16 (-1.19%)

CVNA Carvana
$216.77 /

+42.98 (+24.73%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

ALL Allstate
$93.18 /

+1.185 (+1.29%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

09/22/20 Loop Capital
Global Payments initiated with a Buy at Loop Capital
09/22/20 Bernstein
Bernstein upgrades Amazon.com to Outperform after 16% pullback
09/22/20 Bernstein
Amazon.com upgraded to Outperform from Market Perform at Bernstein
09/20/20 Citi
Kornit Digital upgraded to Buy from Neutral at Citi
PYPL PayPal
$182.48 /

-0.74 (-0.40%)

09/22/20 Loop Capital
PayPal initiated with a Buy at Loop Capital
09/15/20 Baird
PayPal's Venmo remains favored digital wallet by 'wide margin,' says Baird
08/31/20 Keefe Bruyette
KBW boosts PayPal target to $238, names best idea for second half
08/28/20 Truist
MasterCard price target raised to $415 from $375 at Truist
SQ Square
$149.84 /

-1.19 (-0.79%)

09/22/20 Loop Capital
Square initiated with a Buy at Loop Capital
09/16/20 Mizuho
Square lending product could add 10% in gross profit, says Mizuho
08/27/20 Mizuho
Mizuho starts Square with Buy rating, $225 price target
08/26/20 Mizuho
Square initiated with a Buy at Mizuho
TDOC Teladoc
$202.66 /

-0.1 (-0.05%)

09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
CVNA Carvana
$216.77 /

+42.98 (+24.73%)

09/22/20 Goldman Sachs
Carvana upgraded to Buy from Neutral at Goldman Sachs
08/12/20
Fly Intel: Top five analyst initiations
08/11/20 Stifel
Carvana initiated with a Hold at Stifel
08/11/20 Citi
Carvana price target raised to $240 from $120 at Citi
PGR Progressive
$96.20 /

-1.16 (-1.19%)

09/22/20 Keefe Bruyette
Progressive downgraded to Underperform from Market Perform at Keefe Bruyette
09/22/20 Keefe Bruyette
Allstate upgraded to Outperform from Market Perform at Keefe Bruyette
09/14/20 Raymond James
Progressive price target raised to $110 from $100 at Raymond James
09/02/20 MKM Partners
Progressive price target raised to $115 from $90 at MKM Partners
ALL Allstate
$93.18 /

+1.185 (+1.29%)

07/22/20 Citi
Citi opens 'Positive Catalyst Watch' on Allstate shares
07/09/20 B. Riley FBR
National General downgraded to Neutral from Buy at B. Riley FBR
07/09/20 Citi
Allstate acquisition of National an incremental positive, says Citi
TDOC Teladoc
$202.66 /

-0.1 (-0.05%)

SQ Square
$149.84 /

-1.19 (-0.79%)

PYPL PayPal
$182.48 /

-0.74 (-0.40%)

PGR Progressive
$96.20 /

-1.16 (-1.19%)

CVNA Carvana
$216.77 /

+42.98 (+24.73%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

ALL Allstate
$93.18 /

+1.185 (+1.29%)

  • 19
    May
TDOC Teladoc
$202.66 /

-0.1 (-0.05%)

SQ Square
$149.84 /

-1.19 (-0.79%)

PYPL PayPal
$182.48 /

-0.74 (-0.40%)

PGR Progressive
$96.20 /

-1.16 (-1.19%)

CVNA Carvana
$216.77 /

+42.98 (+24.73%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

TDOC Teladoc
$202.66 /

-0.1 (-0.05%)

SQ Square
$149.84 /

-1.19 (-0.79%)

PYPL PayPal
$182.48 /

-0.74 (-0.40%)

CVNA Carvana
$216.77 /

+42.98 (+24.73%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

ALL Allstate
$93.18 /

+1.185 (+1.29%)

TDOC Teladoc
$202.66 /

-0.1 (-0.05%)

SQ Square
$149.84 /

-1.19 (-0.79%)

PYPL PayPal
$182.48 /

-0.74 (-0.40%)

CVNA Carvana
$216.77 /

+42.98 (+24.73%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

AMZN Amazon.com
$3,017.89 /

+56.89 (+1.92%)

Initiation
Teladoc initiated with a Buy at DA Davidson » 08:22
09/22/20
09/22
08:22
09/22/20
08:22
TDOC

Teladoc

/

+

DA Davidson analyst…

DA Davidson analyst Hannah Baade initiated coverage of Teladoc with a Buy rating and $250 price target. The analyst notes that the company is a direct beneficiary of COVID-19, with telehealth utilization rates "soaring" to 16% from historical rate of below 1%. Baade adds that Teladoc is now growing over 60% organically, while its acquisitions have expanded its footprint and generated leverage to "popular direct-to-consumer markets". The analyst further states that the company's Q3 guidance was "conservative", setting up a "likely" beat.

ShowHide Related Items >><<
TDOC Teladoc
/

+

TDOC Teladoc
/

+

09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
TDOC Teladoc
/

+

TDOC Teladoc
/

+

TDOC Teladoc
/

+

TDOC Teladoc
/

+

Initiation
Teladoc initiated with a Buy at DA Davidson » 06:36
09/22/20
09/22
06:36
09/22/20
06:36
TDOC

Teladoc

$202.71 /

-2.96 (-1.44%)

DA Davidson analyst…

DA Davidson analyst Hannah Baade initiated coverage of Teladoc with a Buy rating and $250 price target.

ShowHide Related Items >><<
TDOC Teladoc
$202.71 /

-2.96 (-1.44%)

TDOC Teladoc
$202.71 /

-2.96 (-1.44%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
TDOC Teladoc
$202.71 /

-2.96 (-1.44%)

TDOC Teladoc
$202.71 /

-2.96 (-1.44%)

TDOC Teladoc
$202.71 /

-2.96 (-1.44%)

TDOC Teladoc
$202.71 /

-2.96 (-1.44%)

Over a week ago
Hot Stocks
Amwell says Teladoc patent infringement claims 'lack merit' » 09:58
09/21/20
09/21
09:58
09/21/20
09:58
AMWL

Amwell

$22.93 /

-0.08 (-0.35%)

, TDOC

Teladoc

$199.01 /

-6.66 (-3.24%)

Amwell (AMWL) disclosed…

Amwell (AMWL) disclosed last week that on September 14, it received a letter from Teladoc Health (TDOC) alleging that certain of its cart products and associated peripherals infringe upon their patents. "While we can provide no guarantees about the outcome of any potential dispute, we believe that these claims lack merit and, if Teladoc attempts to bring these claims to court, we intend to defend against them vigorously," Amwell said in a regulatory filing . "Moreover, even if we were found to infringe upon any valid claim of these patents, our revenues from the Carepoints products approximated 5% of our revenues in 2019," it added.

ShowHide Related Items >><<
TDOC Teladoc
$199.01 /

-6.66 (-3.24%)

AMWL Amwell
$22.93 /

-0.08 (-0.35%)

TDOC Teladoc
$199.01 /

-6.66 (-3.24%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
TDOC Teladoc
$199.01 /

-6.66 (-3.24%)

  • 17
    Sep
TDOC Teladoc
$199.01 /

-6.66 (-3.24%)

AMWL Amwell
$22.93 /

-0.08 (-0.35%)

TDOC Teladoc
$199.01 /

-6.66 (-3.24%)

AMWL Amwell
$22.93 /

-0.08 (-0.35%)

TDOC Teladoc
$199.01 /

-6.66 (-3.24%)

Periodicals
Teladoc accuses Amwell of patent infringement, STAT reports » 09:54
09/21/20
09/21
09:54
09/21/20
09:54
AMWL

Amwell

$23.00 /

-0.01 (-0.04%)

, TDOC

Teladoc

$198.69 /

-6.985 (-3.40%)

Teladoc (TDOC) sent a…

Teladoc (TDOC) sent a letter to Amwell (AMWL) on September 14 accusting the company of infringing its patents and demanding that it stop offering the products in question, Rebecca Robbins of STAT reports. Reference Link

ShowHide Related Items >><<
TDOC Teladoc
$198.69 /

-6.985 (-3.40%)

AMWL Amwell
$23.00 /

-0.01 (-0.04%)

TDOC Teladoc
$198.69 /

-6.985 (-3.40%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
TDOC Teladoc
$198.69 /

-6.985 (-3.40%)

  • 17
    Sep
TDOC Teladoc
$198.69 /

-6.985 (-3.40%)

TDOC Teladoc
$198.69 /

-6.985 (-3.40%)

AMWL Amwell
$23.00 /

-0.01 (-0.04%)

TDOC Teladoc
$198.69 /

-6.985 (-3.40%)

Conference/Events
Morgan Stanley to hold a virtual conference » 08:08
09/16/20
09/16
08:08
09/16/20
08:08
ZTS

Zoetis

$162.21 /

+1.33 (+0.83%)

, GLPG

Galapagos

$135.37 /

+0.75 (+0.56%)

, DBVT

DBV Technologies

$1.97 /

-0.005 (-0.25%)

, CI

Cigna

$166.00 /

-6 (-3.49%)

, BDX

Becton Dickinson

$226.09 /

-9.99 (-4.23%)

, AVTR

Avantor

$21.76 /

-0.17 (-0.78%)

, ALC

Alcon

$57.07 /

+0.28 (+0.49%)

, TDOC

Teladoc

$194.91 /

+1.315 (+0.68%)

, INCY

Incyte

$91.48 /

-1.73 (-1.86%)

, DGX

Quest Diagnostics

$113.56 /

+0.74 (+0.66%)

, JNJ

Johnson & Johnson

$148.88 /

+0.485 (+0.33%)

, PAHC

Phibro Animal Health

$18.50 /

+0.34 (+1.87%)

, ABBV

AbbVie

$90.90 /

+0.43 (+0.48%)

, TNDM

TNDM

/

+

, ABC

AmerisourceBergen

$94.93 /

+0.34 (+0.36%)

, CRY

CryoLife

$16.70 /

+0.355 (+2.17%)

, CTLT

Catalent

$84.40 /

+0.5 (+0.60%)

, TXG

10x Genomics

$118.60 /

-2.35 (-1.94%)

, FULC

Fulcrum Therapeutics

$7.84 /

-0.31 (-3.80%)

, KRYS

Krystal Biotech

$46.20 /

-0.92 (-1.95%)

, MYL

Mylan

$15.93 /

+0.15 (+0.95%)

, LLY

Eli Lilly

$150.09 /

+1.09 (+0.73%)

, SUPN

Supernus

$21.95 /

+0.2 (+0.92%)

, SRRK

Scholar Rock

$16.96 /

+0.54 (+3.29%)

, BHC

Bausch Health

$16.26 /

+0.36 (+2.26%)

, HZNP

Horizon Therapeutics

$79.00 /

+2.36 (+3.08%)

, DRNA

Dicerna

$18.00 /

-0.29 (-1.59%)

, RYTM

Rhythm Pharmaceuticals

$30.19 /

-0.3 (-0.98%)

18th Annual Global…

18th Annual Global Healthcare Virtual Conference will be held on September 14-18 with webcasted presentations to begin on September 16 at 8 am. Webcast LinkWebcast Link

ShowHide Related Items >><<
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CRY CryoLife
$16.70 /

+0.355 (+2.17%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

08/18/20 Argus
Elanco price target raised to $30 from $26 at Argus
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
08/14/20 Edward Jones
Zoetis upgraded to Buy from Hold at Edward Jones
08/12/20
Fly Intel: Top five analyst downgrades
GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Jefferies
Galapagos downgraded to Hold from Buy at Jefferies
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
08/19/20 Piper Sandler
AbbVie commercial efforts easier after Gilead CRL, says Piper Sandler
DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

08/06/20 Societe Generale
DBV Technologies downgraded to Sell at Societe Generale after FDA CRL
08/06/20 Societe Generale
DBV Technologies downgraded to Sell from Buy at Societe Generale
08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
CI Cigna
$166.00 /

-6 (-3.49%)

09/11/20 Jefferies
Cigna performance 'seems neglected,' says Jefferies
09/01/20 Cleveland Research
Amazon partnership with Cigna would make sense for both, says Cleveland Research
08/06/20 RBC Capital
Ontrak price target raised to $50 from $35 at RBC Capital
07/01/20 SVB Leerink
Cigna reinstated with a Market Perform at SVB Leerink
BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
08/27/20 Wells Fargo
Abbott not focused on bringing Covid-19 test to home, says Wells Fargo
08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
AVTR Avantor
$21.76 /

-0.17 (-0.78%)

09/14/20 Morgan Stanley
Avantor initiated with an Overweight at Morgan Stanley
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
08/03/20 Truist
Avantor price target raised to $29 from $21 at Truist
07/30/20 JPMorgan
Avantor price target raised to $25 from $18 at JPMorgan
ALC Alcon
$57.07 /

+0.28 (+0.49%)

09/01/20 Berenberg
Alcon price target lowered to CHF 62 from CHF 64 at Berenberg
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
08/27/20 Societe Generale
Alcon downgraded to Sell from Hold at Societe Generale
08/20/20 Stephens
Alcon's new product launches at or above expectations, says Stephens
TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
INCY Incyte
$91.48 /

-1.73 (-1.86%)

09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

09/11/20 Baird
Quest Diagnostics sentiment and valuation missing big picture, says Baird
09/01/20 Deutsche Bank
Quest to see minimal financial impact from Florida news, says Deutsche Bank
08/28/20 Mizuho
Quest, LabCorp weakness yesterday should be bought, says Mizuho
07/29/20
Fly Intel: Top five analyst upgrades
JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/20/20 Morgan Stanley
AbbVie price target raised to $108 from $95 at Morgan Stanley
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

08/31/20 Argus
Argus sees 'solid' growth opportunities for AmerisourceBergen
08/10/20 Credit Suisse
AmerisourceBergen price target raised to $118 from $111 at Credit Suisse
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
CRY CryoLife
$16.70 /

+0.355 (+2.17%)

05/01/20 Lake Street
CryoLife price target raised to $27 from $22 at Lake Street
04/03/20 Lake Street
CryoLife price target lowered to $22 from $38 at Lake Street
04/02/20 Lake Street
CryoLife should emerge stronger in coming years, says Lake Street
04/02/20 Needham
CryoLife price target lowered to $29 from $38 at Needham
CTLT Catalent
$84.40 /

+0.5 (+0.60%)

09/04/20 Deutsche Bank
Catalent price target raised to $91 from $62 at Deutsche Bank
09/01/20 Baird
Catalent price target raised to $100 from $90 at Baird
09/01/20 RBC Capital
Catalent price target raised to $98 from $94 at RBC Capital
TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

09/15/20 JPMorgan
10x Genomics price target raised to $140 from $110 at JPMorgan
09/09/20 Morgan Stanley
10x Genomics initiated with an Overweight at Morgan Stanley
08/12/20 JPMorgan
10x Genomics price target raised to $110 from $95 at JPMorgan
07/10/20
Fly Intel: Top five analyst initiations
FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
08/12/20 H.C. Wainwright
Fulcrum Therapeutics price target lowered to $20 from $28 at H.C. Wainwright
KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

08/19/20 Chardan
Chardan sees valuation upside through 2022 for Krystal Biotech
03/12/20 SMBC Nikko
Krystal Biotech initiated with an Outperform at SMBC Nikko
03/10/20 H.C. Wainwright
Krystal Biotech price target raised to $68 from $59 at H.C. Wainwright
09/26/19 Guggenheim
Krystal Biotech has 'room to run' despite doubling year-to-date, says Guggenheim
MYL Mylan
$15.93 /

+0.15 (+0.95%)

08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
06/18/20 Raymond James
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'
06/18/20 Wedbush
Patent ruling 'creates a significant issue' for Biogen, says Wedbush
LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
09/03/20 Morgan Stanley
Morgan Stanley upgrades Eli Lilly on diabetes, Alzheimer's opportunities
09/03/20 Morgan Stanley
Eli Lilly upgraded to Overweight from Equal Weight at Morgan Stanley
SUPN Supernus
$21.95 /

+0.2 (+0.92%)

06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
06/15/20 Jefferies
Supernus resumed with a Hold at Jefferies
04/30/20 Piper Sandler
Supernus price target raised to $25 from $17 at Piper Sandler
11/08/19 Berenberg
Supernus downgraded to Hold from Buy at Berenberg
SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

03/12/20
Fly Intel: Top five analyst initiations
03/11/20 Baird
Scholar Rock initiated with an Outperform at Baird
BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
08/19/20 Piper Sandler
Bausch Health risk/reward profile remains attractive, says Piper Sandler
08/07/20 Barclays
Bausch Health price target raised to $28 from $25 at Barclays
HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

09/09/20 JPMorgan
Horizon Therapeutics initiated with an Overweight at JPMorgan
08/27/20
Fly Intel: Top five analyst initiations
08/27/20 Piper Sandler
Piper survey points to longer-term growth for Horizon's Krystexxa
08/27/20 Citi
Horizon Therapeutics initiated with a Buy at Citi
DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CRY CryoLife
$16.70 /

+0.355 (+2.17%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

  • 11
    Sep
  • 20
    Aug
  • 07
    Aug
  • 11
    Jun
  • 21
    May
  • 19
    May
  • 21
    May
  • 04
    Feb
  • 30
    Jan
  • 08
    Jan
  • 16
    Oct
  • 09
    Oct
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CI Cigna
$166.00 /

-6 (-3.49%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

Hot Stocks
Teladoc, Livongo Health recommend stockholders vote for merger » 07:18
09/16/20
09/16
07:18
09/16/20
07:18
TDOC

Teladoc

$194.91 /

+1.315 (+0.68%)

, LVGO

Livongo Health

$124.40 /

+0.93 (+0.75%)

Teladoc Health (TDOC) and…

Teladoc Health (TDOC) and Livongo (LVGO) have filed the definitive joint proxy statement and prospectus with the U.S. Securities and Exchange Commission in connection with the proposed merger of the two companies. The definitive joint proxy statement and prospectus is being mailed to all Teladoc Health and Livongo stockholders entitled to vote. The Teladoc Health Special Meeting of stockholders is scheduled to take place on October 29, 2020, at 11:00 a.m., Eastern Time, and will be held virtually. All stockholders of record of Teladoc Health common stock as of the close of business on September 8, 2020, will be entitled to vote at the meeting. The Livongo Special Meeting of stockholders is scheduled to take place on October 29, 2020, at 11:00 a.m., Eastern Time, and will be held virtually. All stockholders of record of Livongo common stock as of the close of business on September 8, 2020, will be entitled to vote at the meeting. The Teladoc and Livongo Boards of Directors each unanimously recommends their respective stockholders vote "For" the proposed merger and other proposals set forth in the definitive joint proxy statement and prospectus. As set forth in the definitive joint proxy statement and prospectus, each share of Livongo will be exchanged for 0.5920 shares of Teladoc Health plus cash consideration of $4.24. Additionally, prior to the closing of the merger, Livongo will pay a cash dividend of $7.09 per share of Livongo common stock to stockholders of Livongo as of a record date immediately prior to closing of the merger. The combination remains on track to close by the end of the fourth quarter of 2020, subject to approval by Teladoc Health and Livongo stockholders and other customary closing conditions.

ShowHide Related Items >><<
TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

LVGO Livongo Health
$124.40 /

+0.93 (+0.75%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
LVGO Livongo Health
$124.40 /

+0.93 (+0.75%)

08/25/20 Guggenheim
Teladoc, Livongo merger strengthens both businesses, says Guggenheim
08/24/20 Stifel
Livongo Health downgraded to Hold from Buy at Stifel
08/21/20 RBC Capital
Teladoc price target raised to $260 from $235 at RBC Capital
TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

LVGO Livongo Health
$124.40 /

+0.93 (+0.75%)

  • 12
    Dec
TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

LVGO Livongo Health
$124.40 /

+0.93 (+0.75%)

Hot Stocks
Magellan Health, Livongo Health to co-market behavioral health services » 06:32
09/09/20
09/09
06:32
09/09/20
06:32
MGLN

Magellan Health

$74.96 /

-0.9 (-1.19%)

, LVGO

Livongo Health

$122.85 /

-3.65 (-2.89%)

Magellan Health (MGLN)…

Magellan Health (MGLN) announced a strategic relationship with Livongo (LVGO), making Livongo for Behavioral Health available to Magellan Health customers and their members as the digital entry point to a wide range of Magellan Health and Livongo solutions and services. With Livongo for Behavioral Health, Magellan can provide its customers and their members, access to consumer-driven digital self-care for mental and behavioral health outside of the clinical setting. As part of the strategic relationship, Livongo and Magellan Health will co-market behavioral health services and collaborate on new product innovations that enhance the member experience and care delivery.

ShowHide Related Items >><<
MGLN Magellan Health
$74.96 /

-0.9 (-1.19%)

LVGO Livongo Health
$122.85 /

-3.65 (-2.89%)

MGLN Magellan Health
$74.96 /

-0.9 (-1.19%)

11/11/19 Jefferies
Magellan Health should trade higher on California win, says Jefferies
11/11/19 Stephens
Magellan Health price target raised to $67 after CA PBM win at Stephens
10/01/19 Stephens
Stephens lowers price targets for MCOs on 2020 election uncertainty
LVGO Livongo Health
$122.85 /

-3.65 (-2.89%)

09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
08/25/20 Guggenheim
Teladoc, Livongo merger strengthens both businesses, says Guggenheim
08/24/20 Stifel
Livongo Health downgraded to Hold from Buy at Stifel
08/21/20 RBC Capital
Teladoc price target raised to $260 from $235 at RBC Capital
MGLN Magellan Health
$74.96 /

-0.9 (-1.19%)

LVGO Livongo Health
$122.85 /

-3.65 (-2.89%)

  • 12
    Dec
LVGO Livongo Health
$122.85 /

-3.65 (-2.89%)

LVGO Livongo Health
$122.85 /

-3.65 (-2.89%)

LVGO Livongo Health
$122.85 /

-3.65 (-2.89%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.